Alberta Investment Management Corp (AIMCo)’s Vanda Pharmaceuticals VNDA Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-50,875	Closed	-$335K	–	1193
2023 Q2	$335K	Hold	50,875	–	–	﹤0.01%	1031
2023 Q1	$345K	Hold	50,875	–	–	﹤0.01%	1056
2022 Q4	$376K	Sell	50,875 -2,235	-4%	-$21.8K	﹤0.01%	951
2022 Q3	$525K	Buy	+53,110	New	+$561K	﹤0.01%	1063
2022 Q2	–	Sell	-107,985	Closed	-$1.22M	–	1358
2022 Q1	$1.22M	Hold	107,985	–	–	0.01%	910
2021 Q4	$1.69M	Hold	107,985	–	–	0.01%	635
2021 Q3	$1.85M	Hold	107,985	–	–	0.02%	650
2021 Q2	$2.32M	Hold	107,985	–	–	0.02%	600
2021 Q1	$1.62M	Buy	107,985 +46,685	+76%	+$756K	0.01%	580
2020 Q4	$805K	Buy	61,300 +29,300	+92%	+$353K	0.01%	714
2020 Q3	$309K	Buy	+32,000	New	+$342K	﹤0.01%	879
2020 Q1	–	Sell	-40,300	Closed	-$661K	–	1043
2019 Q4	$661K	Sell	40,300 -30,600	-43%	-$463K	0.01%	741
2019 Q3	$942K	Buy	+70,900	New	+$988K	0.01%	656

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s VNDA Position: Q3 2023 in Review

Alberta Investment Management Corp (AIMCo) sold out of Vanda Pharmaceuticals (VNDA) in Q3 2023, closing a stake of 50,875 shares — an estimated $335K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in VNDA in Q3 2019 and held it in 13 quarters. The position peaked at $2.32M in Q2 2021. 179 funds tracked by Wall St. Rank hold VNDA as of Q3 2023.

Alberta Investment Management Corp (AIMCo) reported no remaining Vanda Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 50,875 Vanda Pharmaceuticals shares in Q3 2023, an estimated $335K.
Alberta Investment Management Corp (AIMCo) first reported a position in Vanda Pharmaceuticals in Q3 2019 and held it in 13 quarters.
Alberta Investment Management Corp (AIMCo)'s Vanda Pharmaceuticals position peaked at $2.32M in Q2 2021.
179 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2023.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q3 2023, filed 14 Nov 2023.